Natera Announces Third Quarter 2019 Earnings Conference Call

SAN CARLOS, Calif., Oct. 30, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will release results for its third quarter ended September 30, 2019, after the market close on November 6, 2019. Natera will host a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) to discuss its financial results, business activities, and financial outlook.

A webcast replay will be available at investor.natera.com.

About Natera Natera is a global leader in cell-free DNA testing. The mission of the company is to change the management of disease worldwide with a focus on reproductive health, oncology, and organ transplantation. Natera operates an ISO 13485-certified and CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, Calif. It offers a host of proprietary genetic testing services to inform physicians who care for pregnant women, oncologists, and cancer researchers, including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. For more information, visit natera.com. Follow Natera on LinkedIn.

Contacts Investor Relations Mike Brophy, CFO, Natera, 650-249-9090 Media Allison Rogan, pr@natera.com 

View original content to download multimedia:http://www.prnewswire.com/news-releases/natera-announces-third-quarter-2019-earnings-conference-call-300947841.html

SOURCE Natera, Inc.